FDA.reportPublic FDA data

bimatoprost 0.01 MG Drug Implant [Durysta]

RxCUI
2286607
RxNorm name
bimatoprost 0.01 MG Drug Implant [Durysta]
Display name
bimatoprost 0.01 MG Drug Implant [Durysta]
Full name
bimatoprost 0.01 MG Drug Implant [Durysta]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:55

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DURYSTABIMATOPROSTAllergan, Inc.3f59da84-0bcc-4c84-b3e2-e215681ef3412024-10-16Warnings, Adverse reactionsExact identifier
rxcui: 2286607

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3f59da84-0bcc-4c84-b3e2-e215681ef341DURYSTA 10 MCG Intracameral Implant [PSN] · bimatoprost 0.01 MG Drug Implant [Durysta] [SBD] · Durysta 10 MCG Drug Implant [SY]315These highlights do not include all the information needed to use DURYSTA safely and effectively. See full prescribing information for DURYSTA. DURYSTA ® ( bimatoprost intracameral implant), for intracameral administration Initial U.S. Approval: 200120241016